HER2-targeting immunocytokine stimulated anti-tumor immune profile and marked efficacy in mouse tumor model

被引：0

作者：

Lan, K. H. ^{[1
]}

Tsai, C. L. ^{[2
]}

Kuo, S. H. ^{[1
]}

Lan, K. L. ^{[3
]}

机构：

[1] Natl Taiwan Univ Hosp, Oncol, Taipei, Taiwan

[2] Natl Yang Ming Chiao Tung Univ, Biomed Imaging & Radiol Sci, Taipei, Taiwan

[3] Taipei Vet Gen Hosp, Heavy Particles & Radiat Oncol, Taipei, Taiwan

来源：

EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷

关键词：

D O I：

10.1016/j.ejca.2024.114695

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PB162

引用

页码：S69 / S69

页数：1

共 50 条

[41] Anti-tumor effect of aquaporin 3 monoclonal antibody on syngeneic mouse tumor model
Tanaka, Manami
Ito, Anmi
Shiozawa, Seiji
Hara-Chikuma, Mariko
TRANSLATIONAL ONCOLOGY, 2022, 24
[42] Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE)
Thakur, Archana
Kondadasula, Sri Vidya
Ji, Kyungmin
Schalk, Dana L.
Bliemeister, Edwin
Ung, Johnson
Aboukameel, Amro
Casarez, Eli
Sloane, Bonnie F.
Lum, Lawrence G.
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 633 - 656
[43] Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE)
Archana Thakur
Sri Vidya Kondadasula
Kyungmin Ji
Dana L. Schalk
Edwin Bliemeister
Johnson Ung
Amro Aboukameel
Eli Casarez
Bonnie F. Sloane
Lawrence G. Lum
Cancer Immunology, Immunotherapy, 2021, 70 : 633 - 656
[44] Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
Thomas, Susan N.
Vokali, Efthymia
Lund, Amanda W.
Hubbell, Jeffrey A.
Swartz, Melody A.
BIOMATERIALS, 2014, 35 (02) : 814 - 824
[45] Active Immunotherapy With Prostvac® Demonstrates Potent Anti-tumor Efficacy in a Mouse Model of Prostate Cancer
Rountree, Ryan B.
Mandl, Stefanie J.
Cote, Joseph
dela Cruz, Tracy
Giffon, Thierry
Gordon, Evan
Foy, Susan P.
Lombardo, John R.
Trent, Erica
Laus, Reiner
Delcayre, Alain
JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 772 - 773
[46] Tumor targeting using anti-her2 immunoliposomes
Park, JW
Kirpotin, DB
Hong, K
Shalaby, R
Shao, Y
Nielsen, UB
Marks, JD
Papahadjopoulos, D
Benz, CC
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) : 95 - 113
[47] Establishing an immunocompetent mouse model of CAR T anti-tumor efficacy for studies of therapeutic resistance
Rouya, Christopher
Mohrs, Katja
Mccarthy, Craig
Roselli, Emiliano
Lin, John
Kirshner, Jessica
Dilillo, David
JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
[48] A bispecific HER2 targeting FynomAb with superior anti-tumor activity and novel mode of action
Schade, Babette
Brack, Simon
Attinger-Toller, Isabella
Klupsch, Kristina
Woods, Richard
Hachemi, Helen
von der Bey, Ulrike
Kooenig-Friedrich, Susann
Bertschinger, Julian
Grabulovski, Dragan
CANCER RESEARCH, 2014, 74 (19)
[49] Impressive efficacy and safety profile of a novel generation duocarmycin-based HER2-targeting ADC
Dokter, Willem
Ubink, Ruud
van der Lee, Miranda
van der Vleuten, Monique
van Achterberg, Tanja
Jacobs, Danielle
van den Dobbelsteen, Diels
Egging, David
Mattaar, Ellen
Groothuis, Patrick
Beusker, Patrick
Coumans, Ruud
Elgersma, Ronald
Eppink, Michel
de Roo, Guy
Verheijden, Gijs
Timmers, Marco
CANCER RESEARCH, 2014, 74 (19)
[50] Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
Loi, Monica
Marchio, Serena
Becherini, Pamela
Di Paolo, Daniela
Soster, Marco
Curnis, Flavio
Brignole, Chiara
Pagnan, Gabriella
Perri, Patrizia
Caffa, Irene
Longhi, Renato
Nico, Beatrice
Bussolino, Federico
Gambini, Claudio
Ribatti, Domenico
Cilli, Michele
Arap, Wadih
Pasqualini, Renata
Allen, Theresa M.
Corti, Angelo
Ponzoni, Mirco
Pastorino, Fabio
JOURNAL OF CONTROLLED RELEASE, 2010, 145 (01) : 66 - 73

← 1 2 3 4 5 →